Analysis of the cost effectiveness of recombinant versus urinary follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection programs in the United States
2002 ◽
Vol 77
(1)
◽
pp. 107-113
◽
2008 ◽
Vol 89
(6)
◽
pp. 1685-1693
◽
2014 ◽
Vol 102
(6)
◽
pp. 1633-1640.e5
◽
2002 ◽
Vol 78
(3)
◽
pp. 520-528
◽
1995 ◽
Vol 64
(3)
◽
pp. 538-545
◽
Keyword(s):